ScreenerHero

ALNEV Neovacs S.A.

EPA · FR · Healthcare · Biotechnology · neovacs.com
0.1900EUR+2.10%Mkt Cap: 32850 $P/E: —

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for autoimmune disea…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap32.85K USD
Enterprise Value240.06K USD
Revenue (TTM)216.59K USD
Gross Profit46.11K USD
Net Income (TTM)-35.78M USD
Revenue/Share0.42 EUR
Last Price0.1900 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees16
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)1.86
PEG—
EV/EBITDA-0.04
EV/Revenue1.11
P/S0.15
P/B0.00
EPS (TTM)-104187.62
EPS (Forward)0.10
52W Range
0.00020% of range4200.00
52W High4200.00 EUR
52W Low0.0002 EUR
Profitability
Gross Margin11.58%
Oper. Margin-1683.64%
EBITDA Margin0.00%
Profit Margin-8984.51%
ROE-182.23%
ROA-149.13%
Growth
Revenue Growth-59.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.91M USD
CapEx (TTM)86.64K USD
FCF Margin-1918.64%
FCF Yield-12650.46%
Net Debt143.64K USD
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity0.01
Current Ratio0.67
Quick Ratio0.65
Book Value/Sh39.63 EUR
Cash/Share0.08 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10000
Split DateJun 23, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.159.06K
Float—
Insiders—
Institutions—
Technical
SMA 500.4899 (-61.2%)
SMA 20011.41 (-98.3%)
Beta-1247.35
S&P 52W Chg16.45%
Avg Vol (30d)41.01K
Avg Vol (10d)39.74K
Technical Indicators
RSI (14)31.0
MACD-0.0813
MACD Signal-0.0975
MACD Hist.+0.0162
BB Upper0.3082 EUR
BB Middle0.2298 EUR
BB Lower0.1514 EUR
BB Width68.25%
ATR (14)0.0445 EUR
Vol Ratio (20d)0.81x